HOME > BUSINESS
BUSINESS
- Hiring of New Pharmacists Sluggish Due to Decreasing Numbers of Applicants, Tough Competition: Major Dispensing Pharmacies
April 18, 2012
- Eisai Launches Insomnia Treatment Lunesta
April 18, 2012
- Daiichi Sankyo Launches Ranmark for Treatment of Bone Lesions Associated with Cancer; AZ to Copromote Product
April 18, 2012
- Eli Lilly Japan Pinning New Hopes on Solanezumab; Will the Introduction of Medicoeconomic Assessments Help?
April 18, 2012
- MediBIC and Kobe University Hospital to Jointly Form Conference on Pharmacogenomics
April 17, 2012
- JCSOA to Draw Up Guideline for Coping with Business Conflicts this Year
April 17, 2012
- Actelion Receives Approval for NPC Treatment
April 17, 2012
- Ajinomoto Pharmaceuticals to Distribute Lentinan from July: Ajinomoto, Taiho
April 17, 2012
- Generic Names Used in 25% of Prescriptions Issued by GPs: Nihon Chouzai
April 17, 2012
- National, Rosai Hospitals to Buy 9,000 Products in First Joint Purchasing, HQ to Buy Generics by Bulk
April 16, 2012
- Elmed Eisai Found to Make Good Impression on Pharmacists: Survey
April 16, 2012
- Over 60% of Drug Makers Increased Hiring of New Graduates in 2012: Jiho Survey
April 16, 2012
- Ain Pharmaciez to Introduce Electronic Drug Notebooks at All Its Group Stores in July
April 16, 2012
- Takeda to Acquire URL Pharma, Boost US Business Base Through Field of Gout
April 13, 2012
- ECI to Initiate Clinical Research for Cancer Therapy ECI301
April 13, 2012
- AnGes MG to Codevelop High Blood Pressure Treatment Oral Vaccine with Korean Company
April 13, 2012
- US Subsidiary’s CEO Resigns: DSP
April 13, 2012
- AnGes MG Obtains Pharmaceutical Use Patent in Japan for NF-κB Decoy Oligo
April 13, 2012
- Pfizer Focuses on Personalized Medicine for Oncology Area with Xalkori
April 12, 2012
- Teijin Pharma to Expand Overseas Marketing of Febuxostat in 117 Countries
April 12, 2012
ページ
As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…